GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » 3-Year ROIIC %

Beijing Health Guard Biotechnology (BJSE:833575) 3-Year ROIIC % : -12.60% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Beijing Health Guard Biotechnology's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -12.60%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Beijing Health Guard Biotechnology's 3-Year ROIIC % or its related term are showing as below:

BJSE:833575's 3-Year ROIIC % is ranked better than
50.56% of 1416 companies
in the Biotechnology industry
Industry Median: -13.26 vs BJSE:833575: -12.60

Beijing Health Guard Biotechnology 3-Year ROIIC % Historical Data

The historical data trend for Beijing Health Guard Biotechnology's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology 3-Year ROIIC % Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.64 -81.64 -148.92 -34.10 -12.60

Beijing Health Guard Biotechnology Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -12.60 -

Competitive Comparison of Beijing Health Guard Biotechnology's 3-Year ROIIC %

For the Biotechnology subindustry, Beijing Health Guard Biotechnology's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Health Guard Biotechnology's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Beijing Health Guard Biotechnology's 3-Year ROIIC % falls into.



Beijing Health Guard Biotechnology 3-Year ROIIC % Calculation

Beijing Health Guard Biotechnology's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -304.3889232 (Dec. 2023) - -148.222 (Dec. 2020) )/( 1396.387 (Dec. 2023) - 157.362 (Dec. 2020) )
=-156.1669232/1239.025
=-12.60%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Beijing Health Guard Biotechnology  (BJSE:833575) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Beijing Health Guard Biotechnology 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Health Guard Biotechnology (BJSE:833575) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Website
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology (BJSE:833575) Headlines

No Headlines